| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/21/2008 | CN101181629A Medicament abundantly containing FN for curing cervical erosion gynecopathy |
| 05/21/2008 | CN101181626A Transfer factor capsule and preparation method thereof |
| 05/21/2008 | CN101181623A Method for preparing alcohol extraction of white vein ointment |
| 05/21/2008 | CN101181622A Method for preparing water extraction of white vein ointment |
| 05/21/2008 | CN101181603A Facial palsy correcting paste and preparation method thereof |
| 05/21/2008 | CN101181587A Method for preparing stomach pill of aucklandia and amomum fruit |
| 05/21/2008 | CN101181586A Method for preparing qi-regulating pill of aucklandia |
| 05/21/2008 | CN101181495A Prescription with ringing function and uses thereof |
| 05/21/2008 | CN101181486A Depression treating medicine and preparation method thereof |
| 05/21/2008 | CN101181474A Chinese medicine ointment for curing skin diseases as well as producing and detecting method thereof |
| 05/21/2008 | CN101181404A Buccal tablets for curing pharynx sickness as well as preparation method |
| 05/21/2008 | CN101181390A Roxburgh rose juice buccal tablets |
| 05/21/2008 | CN101181375A Pastille soft capsule and preparation method thereof |
| 05/21/2008 | CN101181361A Penyanjing soft capsule and preparation method thereof |
| 05/21/2008 | CN101181358A Santanning dropping pills and preparation method thereof |
| 05/21/2008 | CN101181352A Chinese medicine preparation for curing acute rhinitis and preparation method thereof |
| 05/21/2008 | CN101181346A Duyiwei soft capsule and preparation method thereof |
| 05/21/2008 | CN101181340A Astragalus essence effervescent tablets and preparation method thereof |
| 05/21/2008 | CN101181337A High ester catechin capsule for curing mammary cancer and preparation method thereof |
| 05/21/2008 | CN101181335A Stringy stonecrop dropping pills preparations as well as preparation method |
| 05/21/2008 | CN101181306A Nano-scale compound pearl dimension C lozenge and preparation method thereof |
| 05/21/2008 | CN101181302A Upkeep liquid as well as preservative fluid for plastocyte |
| 05/21/2008 | CN101181295A Pharmaceutical preparation of povidone iodine and preparation method thereof |
| 05/21/2008 | CN101181288A Solid-state molecule disperse preparations of pennogenin series compounds |
| 05/21/2008 | CN101181284A Itraconazole freeze-dry composition for injection and preparation method |
| 05/21/2008 | CN101181282A Hydroxyl radical carthamin yellow carthamus A soft capsule with high bioavailability and preparation method thereof |
| 05/21/2008 | CN101181280A Pirarubicin freeze-dry preparations and preparation method thereof |
| 05/21/2008 | CN101181279A Arificial tears containing trehalose as well as preparation and application method thereof |
| 05/21/2008 | CN101181276A Compound hydrochloric acid doxycycline injection and preparation method thereof |
| 05/21/2008 | CN101181275A Compound terbinafine emulsifiable paste and preparation method thereof |
| 05/21/2008 | CN101181273A Method for preparing chitosan-polyasparagic acid-5efudix nano particle |
| 05/21/2008 | CN101181270A Hydrochloric acid lomefloxacin injection and preparation method thereof |
| 05/21/2008 | CN101181267A Zolmitriptan tongue tablet |
| 05/21/2008 | CN101181266A Biphenyl benzyl azoles emulsion agent and preparation method thereof |
| 05/21/2008 | CN101181265A Nitric acid butoconazole cyclodextrin or cyclodextrin derivant clathrate and preparation method as well as application thereof |
| 05/21/2008 | CN101181263A Treatment of respiratory diseases |
| 05/21/2008 | CN101181260A Rabdosia nail element clathrate and pharmaceutical preparation containing the same |
| 05/21/2008 | CN101181259A Sustained-release agent of nitric acid dinitrate and preparation method thereof |
| 05/21/2008 | CN101181257A Naproxen injection and preparation method thereof |
| 05/21/2008 | CN101181253A Chloromycetin eyedrops with long shelf-life and preparation method thereof |
| 05/21/2008 | CN101181252A Chloromycetin eyedrops with long shelf-life and preparation method thereof |
| 05/21/2008 | CN101181251A Unimycetin eyedrops and preparation method thereof |
| 05/21/2008 | CN101181242A Hydroscopicity microsphere as drug administration system carrier for wound and preparation method |
| 05/21/2008 | CN101181241A Fentanyl composition for nasal administration |
| 05/21/2008 | CN101181239A Unimycetin liquor for eye and preparation method thereof |
| 05/21/2008 | CN101181238A Unimycetin liquor for eye and preparation method thereof |
| 05/21/2008 | CN101181237A Chloromycetin eyedrops with long shelf-lifeand preparation method thereof |
| 05/21/2008 | CN101181236A Exendin agonist peptide formulations and administration method thereof |
| 05/21/2008 | CN101181235A Tantudinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181234A Literdinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181233A Gefitinib sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181232A Marseilledinun sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181231A Sustained-release implantation agent of urotrotiken |
| 05/21/2008 | CN101181230A Estramustine sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181229A Busulfan sustained-release implantation agent for curing entity tumour |
| 05/21/2008 | CN101181226A System for slowing and controlling to release gas bag floationg |
| 05/21/2008 | CN101181225A System for transferring nanometer polyalcohol micelle medicament and preparing method as well as application thereof |
| 05/21/2008 | CN101181224A Solid dispersion of entecavir, pharmaceutical composition and preparation method as well as uses thereof |
| 05/21/2008 | CN100389140C Method of preparing nanometer and micron self assembling body from poly peptide-b-polytetrahydrofuran-b-polypeptide triblock copolymer |
| 05/21/2008 | CN100389122C Cholesterol derivative containing azobenzene group, and its synthesizing method and use |
| 05/21/2008 | CN100388923C Chinese-medicinal preparation and making method for treating acute corneitis and releasing visual fatigue |
| 05/21/2008 | CN100388919C Use of rimexolone in the treatment of dry eye |
| 05/21/2008 | CN100388918C Pharmaceutical compositions based on azetidine derivatives |
| 05/21/2008 | CN100388916C Rate controlling membranes for controlled drug delivery device |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375168 Protein compatible methods and compounds for controlling the morphology and shrinkage of silica derived from polyol-modified silanes |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375080 Microbiocides; reducing microorganisms in foods |
| 05/20/2008 | US7375078 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 05/20/2008 | US7375077 In vivo synthesis of connective tissues |
| 05/20/2008 | US7374930 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 05/20/2008 | US7374784 Method for producing tablets from plant extracts |
| 05/20/2008 | US7374778 Enhanced transport using membrane disruptive agents |
| 05/20/2008 | US7374776 Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers |
| 05/20/2008 | US7374772 A mixture comprising triacetin, tolnaftate fungicide and synthetic vitamin A, for treating skin and nail infections, treating patients with immune compromised, or with diabetes, even healthy person |
| 05/20/2008 | US7374770 Topical applying decarboxylase inhibitor |
| 05/20/2008 | US7374765 Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| 05/20/2008 | US7374762 Monoclonal antibody chemically coupled to maytansinoid, buffer, surfactant, tonicifying amount of sodium chloride, and water; freeze drying |
| 05/20/2008 | CA2499546C Sustained released delivery of amphetamine salts |
| 05/20/2008 | CA2438218C Modulated release particles for aerosol delivery |
| 05/20/2008 | CA2366862C Transdermal therapeutic system and process for its production |
| 05/20/2008 | CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 05/20/2008 | CA2247151C Microencapsulated fluorinated gases for use as imaging agents |
| 05/20/2008 | CA2199664C Novel prodrugs for the therapy of tumors and inflammatory disorders |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2172630C Cellular and serum protein anchors and conjugates |
| 05/20/2008 | CA2171999C Pharmaceutical formulations in form of thixotropic gel |
| 05/20/2008 | CA2166931C Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 05/20/2008 | CA2159610C Prodrugs with enhanced penetration into cells |
| 05/17/2008 | CA2618240A1 Sustained-release formulations of topiramate |
| 05/17/2008 | CA2610652A1 Extended release compositions and methods for their manufacture |
| 05/15/2008 | WO2008058220A2 Transdermal drug delivery system |
| 05/15/2008 | WO2008057442A2 Eyelid scrub composition |
| 05/15/2008 | WO2008056822A1 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
| 05/15/2008 | WO2008056786A1 Composition for skin or mucosal application |
| 05/15/2008 | WO2008056657A1 Lyophilized preparation comprising phenanthridine derivative |
| 05/15/2008 | WO2008056654A1 Polymeric derivative of nucleic acid metabolic antagonist |
| 05/15/2008 | WO2008056623A1 Composition for introduction of nucleic acid |
| 05/15/2008 | WO2008056481A1 Radioactive diagnostic imaging agent |
| 05/15/2008 | WO2008055972A2 N-terminal pegylated prolactin receptor molecules |